Century Therapeutics (IPSC) Intangibles (2021 - 2026)

Century Therapeutics (IPSC) has 4 years of Intangibles data on file, last reported at $34.2 million in Q1 2026.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $34.2 million in Q1 2026; TTM through Mar 2026 was $34.2 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $34.2 million, changed 0.0% from the prior year.
• Intangibles for Q1 2026 stood at $34.2 million, roughly flat from $34.2 million in the prior quarter.
• Over the last five years, Intangibles for IPSC reached as high as $34.2 million in Q4 2024 and fell as low as $33.3 million in Q2 2024.
• Historically, Intangibles has averaged $34.0 million across 3 years, with a median of $34.2 million in 2024.
• On a YoY basis, Intangibles climbed as much as 2.7% in 2025 and fell as far as 0.0% in 2025.
• Year by year, Intangibles stood at $34.2 million in 2024, then changed by 0.0% to $34.2 million in 2025, then changed by 0.0% to $34.2 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $34.2 million in Q1 2026, $34.2 million in Q4 2025, and $34.2 million in Q3 2025.